Cargando…
Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy
BACKGROUND: The adjuvant treatment with Aromatase Inhibitor (AI) is considered standard of care for postmenopausal breast cancer (BC) women with hormone receptor-positive (HR +), however, it often causes adverse effects such as cancer-related fatigue (CRF). The high prevalence of vitamin D deficienc...
Autores principales: | Custódio, Isis Danyelle Dias, Nunes, Fernanda Silva Mazzutti, Lima, Mariana Tavares Miranda, de Carvalho, Kamila Pires, Alves, Débora Santana, Chiaretto, Juliana Freitas, Canto, Paula Philbert Lajolo, Paiva, Carlos Eduardo, de Paiva Maia, Yara Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357315/ https://www.ncbi.nlm.nih.gov/pubmed/35933326 http://dx.doi.org/10.1186/s12885-022-09962-x |
Ejemplares similares
-
Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
por: Lima, Mariana Tavares Miranda, et al.
Publicado: (2017) -
Breast Cancer Survivors Undergoing Endocrine Therapy Have a Worrying Risk Factor Profile for Cardiovascular Diseases
por: Mazzutti, Fernanda S., et al.
Publicado: (2021) -
Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study
por: Marinho, Eduarda da Costa, et al.
Publicado: (2017) -
Relationship between food perceptions and health-related quality of life in a prospective study with breast cancer patients undergoing chemotherapy
por: Marinho, Eduarda da Costa, et al.
Publicado: (2018) -
Health-related quality of life became worse in short-term during treatment in head and neck cancer patients: a prospective study
por: do Nascimento Santos Lima, Emanuelle, et al.
Publicado: (2020)